Iwona Safin, Fysische geneeskunde en revalidatie
0598.983.413 · rovalta.com · 28/09/2026
Iwona Safin, Fysische geneeskunde en revalidatie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOIwona Safin, Fysische geneeskunde en revalidatie is a Private limited company incorporated in 2015. Its registered office is in Overijse.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0598.983.413
- Incorporation
- 26/02/2015
- Legal form
- Private limited company
- Registered office
- Dolf Ledellaan 2
3090 Overijse · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 164,3 k € | +24.1% | 132,4 k € | +31.2% | 101 k € | +17.2% | 86,1 k € | -9.1% | 94,8 k € |
| EBITDA | 163,8 k € | +24.5% | 131,5 k € | +31.4% | 100,1 k € | +17.3% | 85,3 k € | -9.2% | 94 k € |
| Operating result | 155,8 k € | +19.1% | 130,8 k € | +30.6% | 100,1 k € | +17.3% | 85,3 k € | -9.2% | 94 k € |
| Net result | 121,9 k € | +19.3% | 102,2 k € | +29.1% | 79,1 k € | +17.3% | 67,5 k € | -9.5% | 74,5 k € |
| Balance sheet | |||||||||
| Equity | 245,1 k € | +98.9% | 123,2 k € | +23.2% | 100 k € | +7.7% | 92,9 k € | -51.2% | 190,4 k € |
| Total assets | 254,4 k € | +66.9% | 152,4 k € | +36.1% | 111,9 k € | +19.1% | 94 k € | -55.6% | 211,8 k € |
| Cash | 188,6 k € | +67.9% | 112,3 k € | +1.1% | 111,1 k € | +27.9% | 86,9 k € | -58.1% | 207,4 k € |
| Debts | 9,3 k € | -68.2% | 29,2 k € | +145% | 11,9 k € | +1004% | 1,1 k € | -95.0% | 21,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Iwona Safin | DirectorMandateendedManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/07/2026 | 27/06/2025 | 31/07/2024 | 29/06/2023 | 20/08/2022 | 11/08/2021 |
| General meeting | 16/06/2026 | 17/06/2025 | 18/06/2024 | 20/06/2023 | 21/06/2022 | 15/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 16/06/2026 | 17/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 17/06/2025 | 27/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 18/06/2024 | 31/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 20/06/2023 | 29/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 21/06/2022 | 20/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 15/06/2021 | 11/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 16/06/2020 | 09/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 18/06/2019 | 26/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 19/06/2018 | 11/09/2018 | Dutch | |
| Micro model | 31/12/2016 | 20/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 21/06/2016 | 22/08/2016 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Iwona Safin | DirectorMandateendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Dolf Ledellaan 2, 3090 OverijseCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00317766 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Iwona Safin, Fysische geneeskunde en revalidatieCurrent | accounts 2015 → 2025 | Accounts 2025 · 2026-00317766 |
Events
- 2025Annual accounts 2025121,9 k €↑
- 2024Annual accounts 2024102,2 k €↑
- 2023Annual accounts 202379,1 k €↑
- 2022Annual accounts 202267,5 k €↓
- 2021Annual accounts 202174,5 k €↓
- 2020Annual accounts 202094,4 k €↓
- 2019Annual accounts 2019100,5 k €↓
- 2018Annual accounts 2018119,1 k €↑
- 2017Annual accounts 201774,3 k €↑
- 2016Annual accounts 201656,3 k €↑
- 2015Annual accounts 201547,7 k €
- 26/02/2015IncorporationPrivate limited company